JOA - 2026-11-06 - Journal Article; Review
Microenvironment of Bone and Joint Infection: Examining the Microenvironment.
Abbaszadeh A, Damirchi MH, Soleimani M, Ortega-Yago A, Javad Mortazavi SM, Citak M, Parvizi J
Topics
Key Takeaway
Synovial microenvironment-derived biomarkers (extracellular vesicles, cell-free DNA, miRNA) and metagenomic sequencing demonstrate superior pathogen identification in culture-negative PJI compared to conventional culture, though no single biomarker has achieved clinical-grade standardization.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This narrative review evaluates emerging synovial microenvironment biomarkers for PJI diagnosis, focusing on host-derived extracellular vesicles, cell-free nucleic acids, and metagenomic next-generation sequencing (mNGS) as adjuncts or alternatives to conventional culture. Host-derived biomarkers characterize local inflammatory and immune responses with favorable discriminatory capability, while sequencing-based methods improve pathogen identification in culture-negative cases. Clinical implementation is constrained by absence of standardized protocols, high cost, and lack of prospective validation across heterogeneous patient populations.
Key Limitation
No quantitative synthesis of diagnostic performance metrics (sensitivity, specificity, AUC) across reviewed biomarkers, making it impossible to rank or clinically prioritize emerging tests against established standards.
Original Abstract
Periprosthetic joint infection (PJI) is a major complication of arthroplasty, and conventional diagnostic methods for PJI remain limited by suboptimal sensitivity, long turnaround times, high cost, and patient inconvenience, particularly in biofilm-associated and culture-negative infections. Emerging data suggest that the infected joint microenvironment contains host- and pathogen-derived molecular signatures with substantial diagnostic potential. This review evaluates current evidence on microenvironment-related biomarkers in PJI, including host extracellular vesicles, host cell-free nucleic acids (microRNA/cell-free DNA), non-host-derived biomarkers, and sequencing-based pathogen detection techniques. Host-derived biomarkers show favorable discriminatory capability by characterizing inflammatory and immune responses, and metagenomic and sequencing-based technologies improve pathogen identification. Despite encouraging diagnostic performance, widespread clinical implementation remains limited due to a lack of standardization, cost, and limited prospective validation. Future prospective multicenter studies should integrate conventional microbiological methods with molecular and microenvironment-based approaches to improve diagnostic accuracy.